title: Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, OH 45267-0714, USA.
authors.forename: P R
authors.initials: PR
authors.lastname: Fleck
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: A J
authors.initials: AJ
authors.lastname: Dauod
authors.forename: V R
authors.initials: VR
authors.lastname: Peddi
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects*; D003681:Dehydration / Q000453:epidemiology; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus